DDIs to note for COVID-19 treatment
University of Basel, Basel, Switzerland
Catia Marzolini obtained a degree in Pharmacy followed by a PhD in Clinical Pharmacology at the University of Lausanne, Switzerland. She completed a post-doctoral fellowship in the field of pharmacogenetics of drug transporters within the Division of Clinical Pharmacology at Vanderbilt University, Nashville, USA.
Catia Marzolini is currently working as an Associate Professor in the Division of Infectious Diseases & Hospital Epidemiology at the University Hospital of Basel. She provides consultations on complex pharmacological issues. Her research focuses on pharmacological determinants of antiretroviral drug response with a particular interest for the simulation of antiretroviral drug pharmacokinetics and drug-drug interactions in special populations as well as prescribing issues in elderly individuals living with HIV. She has authored/co-authored more than 100 publications. Catia Marzolini is also a member of the Liverpool HIV drug-drug interactions website where she leads the content development of the website. She currently serves on the European AIDS Clinical Society (EACS) guidelines committee where she chairs the drug-drug interaction section and is a member of the scientific board of the Swiss HIV Cohort Study.